What is NDC 60505-0252?

60505-0252 is the product NDC for tizanidine, Tizanidine hydrochloride 4 mg/1 tablet, listed with the FDA by Apotex Corp.. It has 3 package NDCs, shown above in 10- and 11-digit form.

Apotex Corp., NDC labeler code 60505. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for tizanidine?

110 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

tizanidine NDC 60505-0252 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)60505-0252Labeler and product segments. Claims need a package NDC.

Product NDC at billing width60505-0252Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
60505-0252-1	6050502520160505025201	100 TABLET in 1 BOTTLE (60505-0252-1)Marketed from Jan 16, 2004
60505-0252-2	6050502520260505025202	1000 TABLET in 1 BOTTLE (60505-0252-2)Marketed from Jan 16, 2004
60505-0252-3	6050502520360505025203	150 TABLET in 1 BOTTLE (60505-0252-3)Marketed from Jan 16, 2004

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): tizanidine
Generic name (nonproprietary): tizanidine
Active ingredients: Tizanidine hydrochloride — 4 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Apotex Corp.NDC labeler code 60505
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 076533
Marketing start: Jan 16, 2004
Listing expires: Dec 31, 2027
Other FDA classes: Adrenergic alpha2-Agonists (Mechanism)
Identifiers: Product ID 60505-0252_4bf9e490-aaca-0e56-d17d-9f513e09f552SPL ID 4bf9e490-aaca-0e56-d17d-9f513e09f552
Pharmacologic class: Central alpha-2 Adrenergic Agonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N460505025201 followed by a unit qualifier and the quantity

Package 60505-0252-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

The FDA listing for this product does not reference a label (SPL) set.

About NDC 60505-0252

What is NDC 60505-0252?: 60505-0252 is the product NDC for tizanidine, Tizanidine hydrochloride 4 mg/1 tablet, listed with the FDA by Apotex Corp.. It has 3 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: tizanidine.
What is the active ingredient?: Tizanidine hydrochloride.
Who is the labeler?: Apotex Corp., NDC labeler code 60505. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for tizanidine?: 110 other product NDCs are listed under this name. See all tizanidine NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other tizanidine NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Tizanidine	Tizanidine hydrochloride 2 mg/1	TabletOral	Aurobindo Pharma Limited	84386-023	84386-0023-7784386-0023-99
Tizanidine	Tizanidine hydrochloride 4 mg/1	TabletOral	Aurobindo Pharma Limited	84386-024	84386-0024-7784386-0024-99
tizanidine	Tizanidine hydrochloride 4 mg/1	TabletOral	Preferred Pharmaceuticals Inc.	68788-4159	68788-4159-0168788-4159-0268788-4159-03+3 more
Tizanidine	Tizanidine hydrochloride 6 mg/1	CapsuleOral	Direct_Rx	72189-678	72189-0678-30
Tizanidine	Tizanidine hydrochloride 2 mg/1	TabletOral	Medcore LLC	82461-720	82461-0720-60
Tizanidine	Tizanidine hydrochloride 4 mg/1	TabletOral	Medcore LLC	82461-721	82461-0721-60
tizanidine	Tizanidine hydrochloride 2 mg/1	TabletOral	Advanced Rx of Tennessee, LLC	80425-0500	80425-0500-0180425-0500-0280425-0500-03
Tizanidine	Tizanidine hydrochloride 4 mg/1	TabletOral	Preferred Pharmaceuticals Inc.	68788-8802	68788-8802-0168788-8802-0268788-8802-03+3 more
Tizanidine	Tizanidine hydrochloride 4 mg/1	TabletOral	Direct_rx	72189-602	72189-0602-3072189-0602-6072189-0602-90
Tizanidine	Tizanidine hydrochloride 2 mg/1	TabletOral	Direct_rx	72189-599	72189-0599-3072189-0599-6072189-0599-82+1 more

All 111 tizanidine NDCs

Other NDCs under ANDA 076533

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 076533
Product	Strength	Form · route	Labeler	Product NDC
tizanidine	Tizanidine hydrochloride 4 mg/1	TabletOral	Major Pharmaceuticals	0904-6418
tizanidine	Tizanidine hydrochloride 4 mg/1	TabletOral	Cardinal Health 107, LLC	55154-7287
tizanidine	Tizanidine hydrochloride 2 mg/1	TabletOral	Apotex Corp.	60505-0251
tizanidine	Tizanidine hydrochloride 4 mg/1	TabletOral	Proficient Rx LP	63187-145
tizanidine	Tizanidine hydrochloride 4 mg/1	TabletOral	Preferred Pharmaceuticals Inc.	68788-8741
tizanidine	Tizanidine hydrochloride 2 mg/1	TabletOral	Aphena Pharma Solutions - Tennessee, LLC	71610-455
tizanidine	Tizanidine hydrochloride 4 mg/1	TabletOral	Aphena Pharma Solutions - Tennessee, LLC	71610-776